Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial / Olsson, Lg; Swedberg, K; Cleland, Jg; Spark, Pa; Komajda, M; Metra, Marco; Torp Pedersen, C; Remme, Wj; Scherhag, A; Poole Wilson, P; Comet, Investigators. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 9(8):(2007), pp. 795-801.
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial
METRA, Marco;
2007-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
